Our study provides evidence that drugs that normalize intracellular Ca2+ homeostasis can ameliorate insulin resistance by rescuing impaired phosphorylation of AKT, an essential kinase for insulin signaling, and its downstream signaling molecules in the setting of obesity and hyperlipidemia. The gene discussed is AKT1; the disease is hyperlipidemia.